CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

75 hedge funds and large institutions have $84.3M invested in Cascadian Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

18% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 22

19% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 21

Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$94K
Puts
$55K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$23.6M
2
$17.7M
3
$10.1M
4
$6.51M
5
$5.42M
6
$3.22M
7
$3.14M
8
$1.72M
9
$1.42M
10
$1.39M
11
$1.05M
12
$925K
13
$847K
14
$815K
15
$601K
16
$502K
17
$377K
18
$345K
19
$337K
20
$294K
21
$290K
22
$287K
23
$258K
24
$247K
25
$246K